Logo image of DBG.CA

DOUBLEVIEW GOLD CORP (DBG.CA) Stock Fundamental Analysis

TSX-V:DBG - TSX Venture Exchange - CA25862T1003 - Common Stock - Currency: CAD

0.52  +0.02 (+4%)

Fundamental Rating

3

Overall DBG gets a fundamental rating of 3 out of 10. We evaluated DBG against 797 industry peers in the Metals & Mining industry. DBG has a great financial health rating, but its profitability evaluates not so good. DBG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

DBG had negative earnings in the past year.
In the past year DBG has reported a negative cash flow from operations.
DBG had negative earnings in each of the past 5 years.
DBG had a negative operating cash flow in each of the past 5 years.
DBG.CA Yearly Net Income VS EBIT VS OCF VS FCFDBG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M -5M

1.2 Ratios

The Return On Assets of DBG (-6.72%) is better than 65.87% of its industry peers.
DBG has a better Return On Equity (-7.10%) than 69.01% of its industry peers.
Industry RankSector Rank
ROA -6.72%
ROE -7.1%
ROIC N/A
ROA(3y)-7.32%
ROA(5y)-10.01%
ROE(3y)-7.65%
ROE(5y)-10.5%
ROIC(3y)N/A
ROIC(5y)N/A
DBG.CA Yearly ROA, ROE, ROICDBG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20

1.3 Margins

DBG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DBG.CA Yearly Profit, Operating, Gross MarginsDBG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, DBG has more shares outstanding
DBG has more shares outstanding than it did 5 years ago.
DBG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DBG.CA Yearly Shares OutstandingDBG.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DBG.CA Yearly Total Debt VS Total AssetsDBG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

DBG has an Altman-Z score of 44.80. This indicates that DBG is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 44.80, DBG belongs to the best of the industry, outperforming 86.32% of the companies in the same industry.
DBG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 44.8
ROIC/WACCN/A
WACCN/A
DBG.CA Yearly LT Debt VS Equity VS FCFDBG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

DBG has a Current Ratio of 3.64. This indicates that DBG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.64, DBG is in the better half of the industry, outperforming 68.13% of the companies in the same industry.
A Quick Ratio of 3.64 indicates that DBG has no problem at all paying its short term obligations.
DBG has a Quick ratio of 3.64. This is in the better half of the industry: DBG outperforms 68.88% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.64
DBG.CA Yearly Current Assets VS Current LiabilitesDBG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

0

3. Growth

3.1 Past

The earnings per share for DBG have decreased by -7.87% in the last year.
EPS 1Y (TTM)-7.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DBG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DBG.CA Price Earnings VS Forward Price EarningsDBG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DBG.CA Per share dataDBG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DBG!.
Industry RankSector Rank
Dividend Yield N/A

DOUBLEVIEW GOLD CORP

TSX-V:DBG (8/7/2025, 7:00:00 PM)

0.52

+0.02 (+4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-29 2025-07-29
Earnings (Next)10-29 2025-10-29
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners14.95%
Ins Owner ChangeN/A
Market Cap110.46M
Analysts84.44
Price Target1.42 (173.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.25
P/tB 4.25
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.72%
ROE -7.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.32%
ROA(5y)-10.01%
ROE(3y)-7.65%
ROE(5y)-10.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.64
Altman-Z 44.8
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.46%
OCF growth 3YN/A
OCF growth 5YN/A